glp 1 and bone density In an analysis of nearly 150,000 patients, researchers found that people taking GLP-1 medications faced a significantly higher risk of skeletal disorders such as osteoporosis UC Davis Health examines systemic

Oral semaglutide (Rybelsus) provides an alternative, though it was originally approved for type 2 diabetes rather than weight loss

Linus Pauling Institute Oregon State University Updated in April 2012 by: Victoria J

Remind me

A balanced discussion with your OB/GYN, pediatrician, and primary care provider should weigh the risks of delaying metabolic treatment against the theoretical risks of GLP-1 exposure during lactation

This medication is primarily prescribed to treat or prevent conditions caused by a deficiency in Vitamin B12, such as pernicious anaemia and various forms of neuropathy (nerve damage)

Same day, different injection sites